Andrew Peller Limited (ADWPF)
USD 2.83
(0.0%)
USD 2.83
(0.0%)
| Breakdown | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | 36.93 Million | 13.75 Million | 15.59 Million | 41.11 Million | 31.54 Million | 49.04 Million |
| Net Income | -2.85 Million | -3.35 Million | 12.46 Million | 27.78 Million | 23.49 Million | 21.95 Million |
| Depreciation & Amortization | 22.8 Million | 22.52 Million | 21.35 Million | 18.16 Million | 17.75 Million | 12.77 Million |
| Deferred income taxes | -4.73 Million | 1.14 Million | 2.14 Million | 7.57 Million | 1.51 Million | -2.24 Million |
| Stock-based compensation | 554 Thousand | 1.48 Million | 1.39 Million | 937 Thousand | 1.87 Million | 1.22 Million |
| Change in working capital | 10.53 Million | -14.48 Million | -16.35 Million | -7.55 Million | -12.23 Million | 15.13 Million |
| Other non-cash items | 47.1 Million | 6.44 Million | -5.42 Million | -5.79 Million | -861 Thousand | 11.39 Million |
| Investing Cash Flow | -14.83 Million | -20.33 Million | -14.1 Million | -36.53 Million | -23.3 Million | -23.36 Million |
| Investments in PPE | -15.77 Million | -20.33 Million | -22.9 Million | -36.53 Million | -23.3 Million | -23.38 Million |
| Acquisitions | 938 Thousand | - | 8.79 Million | - | - | 18 Thousand |
| Investment purchases | - | - | - | - | - | - |
| Sales/Maturities of investments | - | - | - | - | - | - |
| Other Investing Activities | -414 Thousand | -3.03 Million | -496 Thousand | -18.88 Million | -5.6 Million | -852 Thousand |
| Financing Cash Flow | -22.1 Million | 5.28 Million | -2.92 Million | -1.84 Million | -8.23 Million | -25.67 Million |
| Debt repayment | -6.78 Million | -19.94 Million | -12.88 Million | -11.78 Million | -10.19 Million | -17.17 Million |
| Dividends payments | -10.38 Million | -10.35 Million | -10.19 Million | -9.16 Million | -9.17 Million | -8.56 Million |
| Common Stock Repurchased | - | - | -5.21 Million | - | -6.24 Million | - |
| Common Stock Issuance | - | - | - | - | -3.95 Million | 71 Thousand |
| Other Financing Activities | -1.17 Million | 35.58 Million | -400 Thousand | 19.1 Million | 21.33 Million | -9.07 Million |
| Accounts receivables | -8.08 Million | 2.07 Million | 1.52 Million | 5.2 Million | -4.01 Million | 1.6 Million |
| Accounts payables | -263 Thousand | 2.77 Million | 685 Thousand | -3.05 Million | 1.6 Million | 13.96 Million |
| Inventory | 18.04 Million | -20.74 Million | -17.54 Million | -8.81 Million | -10.45 Million | -218 Thousand |
| Other working capital | 843 Thousand | 1.4 Million | -1.01 Million | -881 Thousand | 627.99 Thousand | -443 Thousand |
| Cash at beginning of period | - | 1.29 Million | 2.73 Million | - | - | - |
| Cash at end of period | - | - | 1.29 Million | 2.73 Million | 1.00 | - |
| Capital Expenditure | -15.77 Million | -20.33 Million | -22.9 Million | -36.53 Million | -23.3 Million | -23.38 Million |
| Effect of forex changes on cash | - | - | - | - | - | - |
| Net cash flow / Change in cash | - | -1.29 Million | -1.44 Million | 2.73 Million | 1.00 | - |
| Free Cash Flow | 21.16 Million | -6.58 Million | -7.3 Million | 4.58 Million | 8.23 Million | 25.65 Million |
| Breakdown | 2024 FY | 2024 Q4 | 2024 Q3 | 2024 Q2 | 2024 Q1 | 2023 FY |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | -2.85 Million | -6.94 Million | -369 Thousand | 5.39 Million | -931 Thousand | -3.35 Million |
| Depreciation & Amortization | 22.8 Million | 5.89 Million | 5.86 Million | 5.63 Million | 5.41 Million | 22.52 Million |
| Deferred income taxes | -4.73 Million | -3.33 Million | -1.11 Million | 704 Thousand | -993 Thousand | 1.14 Million |
| Stock-based compensation | 554 Thousand | -442 Thousand | 213 Thousand | 407 Thousand | 376 Thousand | 1.48 Million |
| Change in working capital | 10.53 Million | 11.06 Million | -11.47 Million | 4.36 Million | 6.57 Million | -14.48 Million |
| Other non-cash items | 47.1 Million | -11.07 Million | 15.86 Million | -474 Thousand | 3.3 Million | 6.44 Million |
| Investing Cash Flow | -14.83 Million | -4.48 Million | -1.88 Million | -5.7 Million | -2.75 Million | -20.33 Million |
| Investments in PPE | -15.77 Million | -4.48 Million | -2.82 Million | -5.7 Million | -2.75 Million | -20.33 Million |
| Acquisitions | 938 Thousand | - | 938 Thousand | - | - | - |
| Investment purchases | - | - | - | - | - | - |
| Sales/Maturities of investments | - | - | - | - | - | - |
| Other Investing Activities | -414 Thousand | -440 Thousand | 578 Thousand | -256 Thousand | -296 Thousand | -3.03 Million |
| Financing Cash Flow | -22.1 Million | 3.44 Million | -7.73 Million | -6.82 Million | -10.99 Million | 5.28 Million |
| Debt repayment | -6.78 Million | -7.19 Million | -5 Million | -2.77 Million | -6.21 Million | -19.94 Million |
| Dividends payments | -10.38 Million | -2.6 Million | -2.59 Million | -2.59 Million | -2.59 Million | -10.35 Million |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | - | - | - | - | - | - |
| Other Financing Activities | -1.17 Million | 199 Thousand | -136 Thousand | -1.46 Million | -2.19 Million | 35.58 Million |
| Accounts receivables | -8.08 Million | -9.91 Million | 22.63 Million | -16.9 Million | -3.89 Million | 2.07 Million |
| Accounts payables | -263 Thousand | 10.32 Million | -11.97 Million | 6.47 Million | -5.08 Million | 2.77 Million |
| Inventory | 18.04 Million | 13.93 Million | -28.05 Million | 14.81 Million | 17.34 Million | -20.74 Million |
| Other working capital | 843 Thousand | -3.29 Million | 5.93 Million | -12 Thousand | -1.78 Million | 1.4 Million |
| Cash at beginning of period | - | 2.86 Million | 3.49 Million | - | - | 1.29 Million |
| Cash at end of period | - | - | 2.86 Million | 3.49 Million | - | - |
| Capital Expenditure | -15.77 Million | -4.48 Million | -2.82 Million | -5.7 Million | -2.75 Million | -20.33 Million |
| Effect of forex changes on cash | - | - | - | - | - | - |
| Net cash flow / Change in cash | - | -2.86 Million | -625 Thousand | 3.49 Million | - | -1.29 Million |
| Free Cash Flow | 21.16 Million | -6.31 Million | 6.16 Million | 10.31 Million | 10.99 Million | -6.58 Million |
QBIO
TNXT
CPI
NUR
603726
3465